Can-Fite BioPharma Ltd., 2026-09-10
A new SEC Form D private-offering notice from Ramat Gan, a $8,306,884 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage biopharmaceutical company developing small molecule drugs for cancer, inflammatory and metabolic diseases via the A3 adenosine receptor pathway
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Tempo Therapeutics, Inc., 2026-09-11, $14.5M, San Diego, CA
- seqWell Inc., 2026-09-10, $1M, Beverly, MA
- ALZHEON, INC., 2026-09-10, $500M, Framingham, MA
- Polyrizon Ltd., 2026-09-10, $4M, Raanana
- Quoin Pharmaceuticals Ltd., 2026-09-10, $50M, Ashburn, VA
- Cloverleaf Bio, Inc., 2026-09-09, $29.6M, New Haven, CT
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.